Personalized medicine driving biobanking demand, says sample management provider
The growing emphasis on personalized medicine is driving the need for biobanking services – demand for which is expected to continue increasing.
The growing emphasis on personalized medicine is driving the need for biobanking services – demand for which is expected to continue increasing.
TapImmune would consider a partnership deal with a major pharmaceutical firm in a non-Caucasian country, such as Japan or China, if “very compelling” from a financial standpoint, says CEO.
Fujifilm Diosynth Biotechnologies has added fill/finish capabilities for late-phase and commercial supply of gene therapies and viral vaccines.
Academic research underpins many of the early success stories in continuous manufacturing. Now, Blair Brettmann and her team are working to write another chapter by applying electrospinning and other techniques to downstream processing.
The UK is investing £3m ($4m) to build a workforce capable of delivering cell and gene therapies to patients at commercial scales.